M

Mediphase Venture Partners

10 employees

Mediphase Venture Partners is a Massachusetts-based venture capital firm focused on healthcare and life sciences companies.

Investor insights

Sectors invested in

Health Care9
Biotechnology7
Pharmaceutical5
multidrug-resistant infections4
Gram-negative antibiotics4
antibiotic resistance4
Antibiotics4
Biopharma4
bacterial resistance4
biopharmaceutical4
Medical3
pharmaceutical sales force tracking and effectiveness research and full service market research supporting the pharmaceutical product life cycle2
Therapeutics2
340B Administration2
Covered Entities2
Contract Pharmacy Services2
Specialty Pharmacy2
HRSA Compliance2
340B Technology2

Funding rounds participated in

$16M sweet spot round size

Most of their 22 investments are in rounds between $7.5M and $37M

Investor type

Venture Capital

Basic info

Industry

higher education

Sectors

Financial Services
Finance
Venture Capital

Date founded

1999

Investments made

U

Undisclosed raised $80M on August 14, 2012

Investors: New Leaf Venture Partners, 5AM Ventures, Delphi Ventures, OrbiMed Advisors and Mediphase Venture Partners

U

Undisclosed raised $62M on July 1, 2012

Investors: Delphi Ventures, 5AM Ventures, OrbiMed Advisors, New Leaf Venture Partners and Mediphase Venture Partners

U

Undisclosed raised $70M on August 8, 2011

Investors: 5AM Ventures, OrbiMed Advisors, New Leaf Venture Partners and Mediphase Venture Partners

U

Undisclosed raised $70M on September 13, 2010

Investors: Delphi Ventures, 5AM Ventures, New Leaf Venture Partners, OrbiMed Advisors and Mediphase Venture Partners

T

Tetraphase raised $45M on June 1, 2010

Investors: F-Prime Capital Partners, Sky Ventures, Flagship Ventures, Excel Venture Management, LLC and Mediphase Venture Partners

I

ImpactRx raised $1.2M on January 11, 2010

Investors: Omega Funds and Mediphase Venture Partners

T

Tetraphase raised $25M on September 22, 2009

Investors: Sky Ventures, Flagship Ventures, F-Prime Capital Partners and Mediphase Venture Partners

T

Tetraphase raised $15M on August 7, 2008

Investors: CMEA Capital, Fidelity Growth Partners, Sky Ventures and Mediphase Venture Partners

W

Wellpartner raised $16M on August 5, 2008

Investors: Montlake Capital, 3i Group plc, -, Greenwood Management and Mediphase Venture Partners

C

Concert Pharmaceuticals raised $37M on April 30, 2008

Investors: TVM Life Science Management Inc, Three Arch Partners, New Leaf Venture Partners, Sky Ventures, QVT Financial LLP, Greylock Partners, Flagship Ventures and Mediphase Venture Partners

FAQ